Friday, March 23, 2018

Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

The systemic administration of cytotoxic chemotherapeutic agents for cancer treatment often has toxic side effects, limiting the usage dose. To increase chemotherapeutic efficacy while reducing toxic effects, ...

from Most Recent Articles: Journal of Nanobiotechnology http://ift.tt/2IIhuN3
via IFTTT

No comments:

Post a Comment